Maternal Health Market, by Type (Hormones, Nutritives, Analgesics, Anti-Infectives, Others), Type of Pregnancy (Intrauterine, Ectopic, Tubal, Others), Risk in Pregnancy (High, Molar), Complications (Miscarriage, Premature Labor and Birth, Others), Delivery Type (Vaginal Delivery, Cesarian Section, Others), application (Hospitals, Clinics, Household, Others) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
The global Maternal Health market size was estimated at USD 23.76 billion in 2023 and is projected to reach USD 61.30 billion in 2030 at a CAGR of 14.50% during the forecast period 2023-2030.
Maternal Health refers to the health of women during pregnancy, childbirth, and the postpartum period. It encompasses the physical, mental and social wellbeing of women during these times. Maternal health is important because it affects the health of both the mother and the baby.
There are several factors that can affect maternal health such as age of the mother, socioeconomic status, location, access to healthcare, lifestyle choices. Maternal Health is a global issue in which, every year, millions of women die from preventable causes related to pregnancy and childbirth. However, there has been progress in recent years. The Maternal Mortality Ratio (MMR) has fallen by 45% since 1990.
The maternal health market is a growing market, driven by the rise in pregnancies, rising awareness of maternal health benefits, and rapid advancements in healthcare sector. The market is also expected to benefit from the rising birth rates and disposable income in developing countries.
The market is segmented on the basis of type, type of pregnancy, complications, delivery type, application and region. Based on type, the market is divided into Hormones, Nutritives, Analgesics, Anti-Infectives, Others. By type of pregnancy, the market is segmented into Intrauterine, Ectopic, Tubal, Others. Based on complication the market is divided into Miscarriage, Premature Labor and Birth, Others. Based on delivery the market is bifurcated into Vaginal Delivery, Cesarian Section, Others. On the basis of application, the market is bifurcated into Hospitals, Clinics, Household, Others. Lastly, on the basis of region the market is segmented into, North America, Europe, Asia-Pacific, Middle East and Africa and South America.
COVID – 19 had an adverse impact on the global maternal health market. This negative impact can be attributed to several factors. Firstly, the pandemic led to lockdowns and restrictions on movements, which made it difficult for women to access healthcare services. This was particularly problematic for women in rural areas. Secondly, the pandemic has led to an increase in maternal mortality, as women were less likely to seek healthcare for complications during pregnancy and childbirth. This is due to a number of factors, including hear of contracting COVID-19, financial constraints and transportation challenges. Moreover, the pandemic led to a decrease in the utilization of maternal health services, such antenatal health care and skilled birth attendance. Lastly, the pandemic led to increased stress and anxiety among pregnant women, which had a negative impact on their health and wellbeing.
COVID-19 had a negative impact on the global maternal health market due to reduced access to healthcare, increased maternal mortality, decreased utilization of maternal health services and increased stress and anxiety among pregnant women. However, increasing pregnancies, rising awareness of maternal health benefits and rapid advancement in the healthcare segment are the major factors that will drive the growth of the market during the forecast period. Moreover, rising birth rates and disposable income in developing countries is also expected to drive the growth of the market further during the forecast period.
Asia Pacific to Dominate the Market
Report Feature |
Descriptions |
---|---|
Growth Rate |
CAGR of 14.50% during the forecasting period, 2023-2030 |
Historical Data |
2019-2021 |
Forecast Years |
2023-2030 |
Base Year |
2022 |
Units Considered |
Revenue in USD billion and CAGR from 2023 to 2030 |
Report Segmentation |
Type, Type of Pregnancy, Risks in pregnancy, complication, delivery type, care, and region |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East, and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, and South Africa (50+ Countries Across the Globe) |
Companies Profiled |
Johnson & Johnson Private Limited, Jiovio Healthcare, McKesson Corporation, MedTech Boston, Merck & Co., Inc., RAND Corporation, SYNAPSE Product Development, International Federation of Pharmaceutical Manufacturers & Associations, Siemens, Agile Therapeutics, Fuji Latex Co, Okamoto Industries Inc., Reckitt Benckiser Group Plc, Sanofi, Arrowhead Regional Medical Center, Cloudnine Group of Hospitals, Carle Foundation Hospital, Ann & Robert H. Lurie Children's Hospital of Chicago, King Faisal Specialist Hospital and Research Centre, Apollo Hospitals Enterprise Ltd |
Available Customization |
In addition to the market data for the Maternal Health Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements. |
The Maternal Health Market is segmented into various segments such as Type, Type of Pregnancy, Risks in pregnancy, complication, delivery type, care and region:
Based on Type
Based on the Type of Pregnancy
Based on the Complication
Based on the Risks of Pregnancy
Based on the Delivery type
Based on the Care
Based on region
The prominent players in the Global Maternal Health market are